Wellington Management Group LLP 13D and 13G filings for Rocket Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-05 7:43 pm Sale | 2025-05-30 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 1,004,476 0.900% | -6,147,245 (-85.95%) | Filing |
| 2025-05-07 10:02 am Sale | 2025-04-30 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 7,151,721 6.700% | -5,474,770 (-43.36%) | Filing |
| 2025-05-07 09:59 am Sale | 2025-03-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 12,626,491 11.800% | -1,368,686 (-9.78%) | Filing |
| 2025-02-10 10:25 am Purchase | 2024-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 13,995,177 13.400% | 2,753,033 (+24.49%) | Filing |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 11,242,144 12.360% | 2,086,045 (+22.78%) | Filing |
| 2024-04-05 09:47 am Purchase | 2024-03-29 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 9,156,099 10.120% | 958,553 (+11.69%) | Filing |
| 2024-02-08 10:17 am Purchase | 2023-12-29 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 8,197,546 9.090% | 4,690,529 (+133.75%) | Filing |
| 2023-02-06 2:56 pm Purchase | 2022-12-30 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 3,507,017 4.450% | 16,138 (+0.46%) | Filing |
| 2022-02-04 09:22 am Purchase | 2021-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Wellington Management Group LLP | 3,490,879 5.420% | 3,490,879 (New Position) | Filing |